2.47k followers • 31 symbols Watchlist by Yahoo Finance
Follow this list to discover and track stocks with the greatest 52-week gain. These are stocks whose price has increased the most over the past 52 weeks (percent change). This list is generated daily, the gains are based on today's closing price and limited to the top 30 stocks that meet the criteria.
There's more to the story for these Canadian marijuana stocks' gains -- or lack thereof -- in 2018.
When Canada legalized recreational marijuana in October, it emerged as the world leader in the industry — and U.S. companies are scrambling to get in on the action. Uruguay may have been the first country to legalize pot, but the South American country's market is dwarfed by Canada's. And while a majority of U.S. states have legalized marijuana to varying degrees, contradictory federal laws have U.S. companies reluctant to invest here. — Marlboro maker Altria Group Inc., which is headquartered in Richmond, Virginia, is paying $1.8 billion for a 45 percent stake in Cronos Group.
Shares of Stitch Fix, Inc. (SFIX) plummeted roughly 8% Friday as part of the larger market downturn, just one trading day before it reports its quarterly earnings results.
Today, Aphria (APHA)(APHQF) resumed a sharp sell-off in its stock from early this month after surging a whopping 51% yesterday. Now, let’s find out what could be driving Aphria stock down today. Grego alleged that “Aphria had diverted funds into inflated investments held by insiders.” Since then, these allegations have taken a massive toll on investors’ confidence.
The latest list of new buys by the best mutual funds shows a focus on large cap stocks like Berkshire, led by Warren Buffett, CVS, Starbucks and Adobe.
Lululemon Athletica (LULU) reported impressive results for the third quarter of fiscal 2019, which ended on October 28. The company’s net revenue surged 20.8% to $747.7 million, beating analysts’ expectation of $737.45 million.
On December 6, Aphria’s (APHQF) short seller, Hindenburg Research, released its Part 2 on what it found to be further malice in the company’s acquisition efforts. According to the research, this acquisition showed a 5 million Canadian dollar gain to Aphria’s insider in a matter of six days. Further, the report pointed out that Aphria’s CEO, Vic Neufeld, was also a part of the “discount round” in which Aphria purchased companies at overpriced valuations. Even more damning was the short seller’s observation that the SEC had alleged that the individuals that Aphria purchased companies from were involved in pump and dump schemes.
Aprhia (APHQF) recovered by nearly 50% on December 6 due to its further commitment to relieve investors’ fears related to its Latin America business. The company appointed a special committee that consists of independent directors who will be tasked with reviewing the legitimacy of the company’s acquisitions in Latin America. The above chart shows that Aphria (APHQF) is among the top ten holdings in the Horizons Marijuana Life Sciences ETF (HMMJ).
Advanced Micro Devices (AMD) has been looking to tap the high-end data center market, which is governed by Intel’s (INTC) Xeon CPUs (central processing units) and NVIDIA’s (NVDA) Tesla GPUs (graphics processing units). Intel and NVIDIA have launched several suites and generations of data center and AI (artificial intelligence) products.
On December 7, Altria officially announced that it acquired a ~45% stake in the company to the tune of $1.8 billion. Given that Altria has been in the tobacco business for nearly three decades, the cannabis business makes sense for the business.
Advanced Micro Devices (AMD) is looking to boost its EESC (Enterprise, Embedded, and Semi-Custom) business by growing its share of the high-margin data center market. In 2017, it launched its 14nm (nanometer) EPYC server CPUs (central processing units), which compete with Intel’s (INTC) 14nm Xeon server CPUs.
On December 6, Aphria (APHQF) (APHA) clawed back after a brutal sell-off in which the company lost nearly half of its value in just the first three days of this week. In contrast, Aurora Cannabis (ACBFF), Tilray (TLRY), and Cronos Group (CRON) were all in the negative territory. At the heart of Aphria’s downfall was a short seller’s allegation that acquisitions in Latin American were made at inflated prices.